Met shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infectionPLoS pathogensAugust 1, 2023Phan QT, Solis NV, Cravener MV, Swidergall M, Lin J, Huang MY, Liu H, Singh S, Ibrahim AS, Mazzone M, et al.

(4) Tyrosine phosphorylation of the scaffold protein IQGAP1 in the MET pathway alters functionThe Journal of biological chemistryDecember 25, 2020Hedman AC, McNulty DE, Li Z, Gorisse L, Annan RS, Sacks DB.

(7) Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric CancerInternational journal of nanomedicineJanuary 1, 2020Zhang Q, Zhang H, Ning T, Liu D, Deng T, Liu R, Bai M, Zhu K, Li J, Fan Q, et al.

(8) MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in GlioblastomaCancer researchJanuary 1, 2020Zhang Y, Nguyen TTT, Shang E, Mela A, Humala N, Mahajan A, Zhao J, Shu C, Torrini C, Sanchez-Quintero MJ, et al.

(9) Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer CellsAdvanced pharmaceutical bulletinAugust 1, 2018Majidi Zolbanin N, Jafari R, Majidi J, Atyabi F, Yousefi M, Jadidi-Niaragh F, Aghebati-Maleki L, Shanehbandi D, Soltani Zangbar MS, Nayebi AM.

(10) Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma ProgressionCancer researchJuly 15, 2018Kumar D, New J, Vishwakarma V, Joshi R, Enders J, Lin F, Dasari S, Gutierrez WR, Leef G, Ponnurangam S, et al.

(13) Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing GlioblastomaAnticancer researchJuly 1, 2017Okuda T, Tasaki T, Nakata S, Yamashita K, Yoshioka H, Izumoto S, Kato A, Fujita M.

(15) Helicobacter pylori CagA Protein Negatively Regulates Autophagy and Promotes Inflammatory Response via c-Met-PI3K/Akt-mTOR Signaling PathwayFrontiers in cellular and infection microbiologyJanuary 1, 2017Li N, Tang B, Jia YP, Zhu P, Zhuang Y, Fang Y, Li Q, Wang K, Zhang WJ, Guo G, et al.

(16) Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulationEur J CancerSeptember 1, 2016Qian G, Wang D, Magliocca KR, Hu Z, Nannapaneni S, Kim S, Chen Z, Sun SY, Shin DM, Saba NF, et al.

(17) Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsNature communicationsJune 10, 2016Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, et al.

(20) Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinomaJournal of experimental & clinical cancer research : CROctober 12, 2015Xiang Q, Zhen Z, Deng DY, Wang J, Chen Y, Li J, Zhang Y, Wang F, Chen N, Chen H, et al.

Met shRNA Plasmid (h)